Payment overview · 2025
General Payments
$29.13
1 reported records · 1 companies
Healthcare provider profile · identity verified
Karla Tejada Arias, MD
Allopathic & Osteopathic Physicians|Internal Medicine · NEW HAVEN, CT · NPI 1104347905
Verified facts
What the public records show
CMS Open Payments records show Karla Tejada Arias, MD received $29.13 in general payments during 2025 across 1 reported records.
Exact Sciences Corporation accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Exact Sciences Corporation | Unresolved — no canonical attribution shown | $29.13 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $29.13 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Cologuard Collection Kit Normalized: cologuard collection kit |
Device | Exact Sciences Corporation | $29.13 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
None of this doctor’s payer companies has same-entity product evidence that passes the publication threshold. The site does not infer company ownership, affiliates, or generic manufacturers.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 737 | 220 |
| Amlodipine Besylate | Amlodipine Besylate | 689 | 169 |
| Gabapentin | Gabapentin | 483 | 128 |
| Pantoprazole Sodium | Pantoprazole Sodium | 441 | 121 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 434 | 124 |
| Lisinopril | Lisinopril | 415 | 113 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 377 | 85 |
| Metformin Hcl | Metformin Hcl | 365 | 97 |
| Ozempic | Semaglutide | 361 | 68 |
| Levothyroxine Sodium | Levothyroxine Sodium | 323 | 76 |
| Diclofenac Sodium | Diclofenac Sodium | 320 | 92 |
| Losartan Potassium | Losartan Potassium | 269 | 92 |
| Carvedilol | Carvedilol | 235 | 52 |
| Trazodone Hcl | Trazodone Hcl | 212 | 60 |
| Metoprolol Succinate | Metoprolol Succinate | 207 | 47 |
| Hydrochlorothiazide | Hydrochlorothiazide | 206 | 58 |
| Jardiance | Empagliflozin | 203 | 61 |
| Montelukast Sodium | Montelukast Sodium | 203 | 47 |
| Omeprazole | Omeprazole | 178 | 45 |
| Mirtazapine | Mirtazapine | 171 | 43 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 153 | 35 |
| Fluticasone Propionate | Fluticasone Propionate | 150 | 53 |
| Donepezil Hcl | Donepezil Hcl | 139 | 32 |
| Trulicity | Dulaglutide | 137 | 25 |
| Tamsulosin Hcl | Tamsulosin Hcl | 136 | 34 |
| Alendronate Sodium | Alendronate Sodium | 128 | 28 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 127 | 35 |
| Furosemide | Furosemide | 126 | 45 |
| Eliquis | Apixaban | 125 | 33 |
| Famotidine | Famotidine | 123 | 49 |
| Sertraline Hcl | Sertraline Hcl | 117 | 32 |
| Janumet | Sitagliptin Phos/Metformin Hcl | 115 | 34 |
| Duloxetine Hcl | Duloxetine Hcl | 114 | 33 |
| Spironolactone | Spironolactone | 92 | 22 |
| Arexvy | Rsvpref3 Antigen/As01e/Pf | 87 | 87 |
| Meclizine Hcl | Meclizine Hcl | 86 | 24 |
| Glipizide | Glipizide | 84 | 26 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 84 | 43 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 82 | 25 |
| Tramadol Hcl | Tramadol Hcl | 82 | 22 |
| Escitalopram Oxalate | Escitalopram Oxalate | 81 | 25 |
| Pregabalin | Pregabalin | 79 | 21 |
| Shingrix | Varicella-Zoster Ge/As01b/Pf | 79 | 62 |
| Alcohol Pads | Alcohol Antiseptic Pads | 77 | 23 |
| Januvia | Sitagliptin Phosphate | 77 | 24 |
| Fluoxetine Hcl | Fluoxetine Hcl | 76 | 18 |
| Ibuprofen | Ibuprofen | 75 | 40 |
| Metformin Hcl Er | Metformin Hcl | 75 | 29 |
| Ventolin Hfa | Albuterol Sulfate | 75 | 22 |
| Farxiga | Dapagliflozin Propanediol | 74 | 20 |
| Pravastatin Sodium | Pravastatin Sodium | 74 | 22 |
| Meloxicam | Meloxicam | 70 | 28 |
| Clopidogrel | Clopidogrel Bisulfate | 62 | 16 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 61 | 15 |
| Symbicort | Budesonide/Formoterol Fumarate | 60 | 12 |
| Simvastatin | Simvastatin | 58 | 16 |
| Ezetimibe | Ezetimibe | 56 | 18 |
| Dicyclomine Hcl | Dicyclomine Hcl | 54 | suppressed |
| Naproxen | Naproxen | 54 | 24 |
| Propranolol Hcl | Propranolol Hcl | 54 | 13 |
| Lidocaine | Lidocaine | 53 | 19 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 53 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 52 | 21 |
| Allopurinol | Allopurinol | 49 | 12 |
| Valsartan | Valsartan | 47 | 16 |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 46 | 13 |
| Ketoconazole | Ketoconazole | 46 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 46 | 13 |
| Citalopram Hbr | Citalopram Hydrobromide | 45 | 12 |
| Bupropion Xl | Bupropion Hcl | 43 | 15 |
| Amitriptyline Hcl | Amitriptyline Hcl | 42 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 42 | 11 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 42 | 16 |
| Metronidazole | Metronidazole | 41 | suppressed |
| Mounjaro | Tirzepatide | 41 | suppressed |
| Linzess | Linaclotide | 40 | 12 |
| Loperamide | Loperamide Hcl | 40 | suppressed |
| Easy Touch Alcohol Prep Pads | Alcohol Antiseptic Pads | 39 | suppressed |
| Latanoprost | Latanoprost | 39 | 11 |
| Hydrocortisone | Hydrocortisone | 38 | 12 |
| Memantine Hcl | Memantine Hcl | 38 | 13 |
| Metoprolol Tartrate | Metoprolol Tartrate | 38 | 16 |
| Chlorthalidone | Chlorthalidone | 37 | suppressed |
| Levetiracetam | Levetiracetam | 37 | suppressed |
| Bumetanide | Bumetanide | 36 | 12 |
| Finasteride | Finasteride | 36 | suppressed |
| Glipizide Er | Glipizide | 36 | 11 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 36 | suppressed |
| Alprazolam | Alprazolam | 35 | suppressed |
| Clotrimazole | Clotrimazole | 34 | 11 |
| Ammonium Lactate | Ammonium Lactate | 33 | 17 |
| Boostrix Tdap | Diphth,pertuss(Acell),tet Vac | 32 | 28 |
| Clonazepam | Clonazepam | 32 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 32 | 16 |
| Pioglitazone Hcl | Pioglitazone Hcl | 32 | suppressed |
| Levemir Flexpen | Insulin Detemir | 31 | suppressed |
| Atenolol | Atenolol | 30 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 30 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 30 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 30 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 29 | suppressed |
| Lactulose | Lactulose | 29 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 28 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 28 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 27 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 27 | suppressed |
| Prednisone | Prednisone | 27 | 22 |
| Spiriva Handihaler | Tiotropium Bromide | 27 | suppressed |
| Comfort Ez Pen Needle | Pen Needle, Diabetic | 26 | 11 |
| Irbesartan | Irbesartan | 26 | suppressed |
| Lorazepam | Lorazepam | 26 | suppressed |
| Baclofen | Baclofen | 25 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 25 | suppressed |
| Advair Hfa | Fluticasone Propion/Salmeterol | 24 | suppressed |
| Aripiprazole | Aripiprazole | 24 | suppressed |
| Lubiprostone | Lubiprostone | 24 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 23 | 20 |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 23 | 11 |
| Myrbetriq | Mirabegron | 23 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 22 | suppressed |
| Entresto | Sacubitril/Valsartan | 22 | suppressed |
| Colchicine | Colchicine | 21 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 21 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 21 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 21 | suppressed |
| Torsemide | Torsemide | 21 | suppressed |
| Janumet Xr | Sitagliptin Phos/Metformin Hcl | 20 | suppressed |
| Soliqua 100-33 | Insulin Glargine/Lixisenatide | 20 | suppressed |
| Tresiba Flextouch U-200 | Insulin Degludec | 20 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 19 | suppressed |
| Nystatin | Nystatin | 19 | 13 |
| Ondansetron Odt | Ondansetron | 19 | suppressed |
| Potassium Chloride | Potassium Chloride | 19 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 19 | suppressed |
| Advair Diskus | Fluticasone Propion/Salmeterol | 18 | suppressed |
| Ultra-Fine Nano Pen Needle | Pen Needle, Diabetic | 18 | 13 |
| Calcitriol | Calcitriol | 17 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 17 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 16 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 16 | suppressed |
| Humalog Mix 75-25 Kwikpen | Insulin Lispro Protamin/Lispro | 16 | suppressed |
| Ranolazine Er | Ranolazine | 16 | suppressed |
| Sucralfate | Sucralfate | 16 | suppressed |
| Tradjenta | Linagliptin | 16 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 16 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 16 | suppressed |
| Glimepiride | Glimepiride | 15 | suppressed |
| Humulin 70-30 | Insulin Nph Hum/Reg Insulin Hm | 15 | suppressed |
| Olanzapine | Olanzapine | 15 | suppressed |
| Azithromycin | Azithromycin | 14 | 13 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 14 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 14 | suppressed |
| Mresvia | Rsv Vaccine, Pref, Mrna/Pf | 14 | 14 |
| Rybelsus | Semaglutide | 14 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 14 | suppressed |
| Trueplus Pen Needle | Pen Needle, Diabetic | 14 | suppressed |
| Xarelto | Rivaroxaban | 14 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 13 | suppressed |
| Diazepam | Diazepam | 13 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 13 | suppressed |
| Fenofibric Acid | Fenofibric Acid (Choline) | 13 | suppressed |
| Fluticasone Propionate Hfa | Fluticasone Propionate | 13 | suppressed |
| Humalog Mix 75-25 | Insulin Lispro Protamin/Lispro | 13 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 13 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 13 | suppressed |
| Clindamycin Phosphate | Clindamycin Phosphate | 12 | suppressed |
| Estradiol | Estradiol | 12 | suppressed |
| Ibandronate Sodium | Ibandronate Sodium | 12 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 12 | suppressed |
| Methimazole | Methimazole | 12 | suppressed |
| Minocycline Hcl | Minocycline Hcl | 12 | suppressed |
| Nyamyc | Nystatin | 12 | suppressed |
| Synthroid | Levothyroxine Sodium | 12 | suppressed |
| Trintellix | Vortioxetine Hydrobromide | 12 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 11 | suppressed |
| Amlodipine-Valsartan | Amlodipine Besylate/Valsartan | 11 | suppressed |
| Cyanocobalamin Injection | Cyanocobalamin (Vitamin B-12) | 11 | suppressed |
| Humalog | Insulin Lispro | 11 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 11 | suppressed |
| Mometasone Furoate | Mometasone Furoate | 11 | suppressed |
| Mupirocin | Mupirocin | 11 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 11 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $29.13 · 1 records | Exact Sciences Corporation | Cologuard Collection Kit | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error